Index
Module 1 • Professional Practice
Evolution & Validation of Practice Standards
80%
Data Tables
Evolution & Validation of Practice Standards
Eric W. Mueller ~3 min read Module 1 of 20
36
/ 45

Evolution and Validation 0f Practice Standards, Training, and Professional Development

Table 1. Critical Care Pharmacy Services in Level 1 Critical Care Centers (Crit Care Med 2020;48:1375-82)

Patient Care

Essential:

β€’

Rounding with interdisciplinary team

β€’

Assists with informed pharmacotherapy decisions

β€’

Provision of drug information to the critical care team

β€’

Provision of drug therapy education to critical care team

β€’

Assists with prevention of inappropriate drug therapy

β€’

Provides clinical consultation for pharmacotherapeutic issues related to critical illness

β€’

Medication consults are available 24 hr/d, 7 d/wk

β€’

Provision of pharmacokinetic monitoring and therapeutic adjustments for targeted drugs

β€’

Review of medication history for determination if maintenance therapy should be continued

β€’

Medication reconciliation services for ICU patients upon admission, transfer, and discharge

β€’

Prospective review of all orders for verification of appropriateness

β€’

Patient and/or caregiver medication therapy education

β€’

Performance of independent patient assessments, e.g., pain/agitation, delirium, nutrition

β€’

Response to cardiac life support by ACLS certified pharmacists 24 hr/d, 7 d/wk

β€’

Response to other resuscitation and time-dependent emergencies in the hospital

β€’

Provision of stewardship of antimicrobials and other selected medications

β€’

Collaboration with other pharmacists within the hospital as needed

β€’

Provision of nutrition therapy plan and modifications in concert with clinical dieticians

β€’

Use of medical record for communication with other healthcare professionals

β€’

Documentation of patient care and economic impact of services

β€’

Documentation of all clinical activities

β€’

Pharmacy liaison with other interdisciplinary team members relative to medication policies, procedures, guide-

lines, and pathways

β€’

Utilizes pharmacoeconomic analyses to evaluate new critical care pharmacotherapeutic agents

β€’

Proactive in designing, prioritizing, and promoting new clinical pharmacy programs

β€’

Evaluation of clinical pharmacy services for stakeholder satisfaction, significance, and economic value

β€’

Participation in planning preparedness and implementation of processes for disaster and mass casualties

β€’

Majority of time dedicated to critical care services

β€’

Patient care time devoted to care of the critically ill patients

β€’

Decentralized clinical services 24 hr/d

β€’

Development of critical care pharmacist β€œteams”

β€’

Appropriate pharmacist-to-patient ratio based on patient acuity and complexity

Desirable:

β€’

Provision of medication management problems documentation of progress notes daily

β€’

Preparation and presentation of drug monographs to the P&T Committee

β€’

Provision of telemedicine services if onsite critical care pharmacists are absent

HD Video Explanation β€” Synchronized with PDF
Starts at: minute 35 Open on YouTube